GridAI Technologies (GRDX) Accounts Payables (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Accounts Payables came in at $3.4 million in Q4 2025, up 14.27% YoY from $3.0 million in Q4 2024, and down 32.01% on a QoQ basis from $5.0 million in Q3 2025.
GridAI Technologies (GRDX) Accounts Payables (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Accounts Payables data on file, last reported at $3.4 million in Q4 2025.
- Quarterly Accounts Payables rose 14.27% year-over-year to $3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (up 14.27% YoY) and the FY2025 annual result came in at $3.4 million, up 14.27% from the prior year.
- Accounts Payables declined to $3.4 million in Q4 2025, from $5.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $18.6 million in Q3 2021 to a low of $469760.0 in Q1 2023.
- A 5-year average of $3.3 million and a median of $2.8 million in 2021 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2021 — Accounts Payables surged 1002.19% — and 2023, when it tumbled 86.38%.
- Tracing GRDX's Accounts Payables over 5 years: stood at $2.7 million in 2021, then slumped by 73.41% to $720040.0 in 2022, then slipped by 23.02% to $554277.0 in 2023, then soared by 433.89% to $3.0 million in 2024, then grew by 14.27% to $3.4 million in 2025.
- The last three Accounts Payables figures came in at $3.4 million (Q4 2025), $5.0 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | 35.57 Mn |
| 10 | GridAI Technologies | 5.93 Mn | 5.93 Mn | - | 3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.38 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 554,277.00 |
| Sep 30, 2023 | 579,291.00 |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 469,760.00 |
| Dec 31, 2022 | 720,040.00 |
| Sep 30, 2022 | 3.58 Mn |
| Jun 30, 2022 | 3.97 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Dec 31, 2021 | 2.71 Mn |
| Sep 30, 2021 | 18.58 Mn |
| Jun 30, 2021 | 4.64 Mn |
| Mar 31, 2021 | 1.71 Mn |